k.roos

TL2 · Kuopio

Contributes reviews on supplier material. Based in Kuopio.

Joined 31 October 2024 · last posted 1d

94Posts here

1Topics

0Solutions

128Likes received

162Likes given

20Badges

101Days visited

1.1kPosts read

Recent activity

Full stream

Common supplements people ask about, assessed one at a time Replied, post #105 · Practice › Interactions · 27 Jul 2026 · 22 likes Research-use-only compounds have no interaction data of any kind, because interaction studies are done on medicines being developed for use in people. Small point, but…
Revisiting: Protein density versus volume when you cannot eat much Replied, post #103 · Nutrition & Training › Protein & intake · 25 Jul 2026 · 0 likes Confirming post #100 from a second method, which matters more than confirming it from a second person. Leucine and MPS: leucine stimulates muscle protein synthesis at a…
Micro-titration: a disputed topic, argued properly — one year on Replied, post #67 · Practice › Dosing & titration · 23 Jul 2026 · 31 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
What a certificate commits its issuer to Replied, post #82 · Analytics › COA interpretation · 22 Jul 2026 · 4 likes Confirming post #80 from a second method, which matters more than confirming it from a second person. An itemised related-substances table with retention times says…
NHS criteria and how they are applied in practice Replied, post #38 · Regional › UK & Ireland · 22 Jul 2026 · 26 likes Trying to state the NHS criteria position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes that test.
Coming back to: Telehealth prescribing models in the US Replied, post #24 · Regional › North America · 22 Jul 2026 · 30 likes Answering the Telehealth prescribing models question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on…
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #41 · Compounds › Repair & healing peptides · 19 Jul 2026 · 31 likes Stability in solution is the practical constraint. Dry, these keep well; reconstituted, the supplier's own data usually covers a shorter period than people assume.
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #35 · Practice › Dosing & titration · 19 Jul 2026 · 22 likes The four-week step is a trial convention, not a pharmacological constant. It is roughly four half-lives for a week-long half-life, which is the interval at which you…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #85 · Evidence › Journal club · 19 Jul 2026 · 0 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend. I would rather say I do not know than round it up to…
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #51 · Practice › Interactions · 16 Jul 2026 · 8 likes On post #47 — agreed on the reasoning, with one qualification. Before the thread moves on from Antibiotics — what is the sample size behind the claim? I am not being…
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #26 · Evidence › Meta-analyses · 14 Jul 2026 · 4 likes Filing a mild objection to the consensus on Risk-of-bias tools. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
[2026 update] Regional warehouse stock versus direct despatch Replied, post #133 · Sourcing › Logistics · 13 Jul 2026 · 24 likes What I want from this Regional warehouse stock versus direct thread is the list of things that would need to be true for the claim to hold. If we can write that list,…